We are live on ! Find out more
OPPM

Opus Point Partners Management Portfolio holdings

AUM $55.3M
1-Year Est. Return 7.48%
This Fund
S&P 500
This Quarter Est. Return
+20.38%
1 Year Est. Return
-7.48%
3 Year Est. Return
+85.18%
5 Year Est. Return
+168.21%
10 Year Est. Return
–
AUM
$101M
AUM Growth
–
Cap. Flow
+$93.1M
Cap. Flow %
92.16%
Top 10 Hldgs %
37.84%
Holding
57
New
57
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BIB icon
ProShares Ultra NASDAQ Biotechnology
BIB
+$4.48M
2
INCY icon
Incyte
INCY
+$3.98M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.64M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$3.56M
5
CELG
Celgene Corp
CELG
+$3.48M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 70.4%
2 Miscellaneous 29.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
51
Gilead Sciences
GILD
$185B
$408K 0.4%
+4,328
New +$448K
ALXN
52
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
$355K 0.35%
+100
New +$18.5K
XOMA
53
DELISTED
Xoma
XOMA
$287K 0.28%
+4,000
New +$343K
BIIB icon
54
CALL
Biogen
BIIB
$32.7B
$269K 0.27%
+120
New +$38.8K
PCYC
55
CALL
DELISTED
PHARMACYCLICS INC
PCYC
$37K 0.04%
+150
New +$19.2K
EXAS
56
PUT
DELISTED
Exact Sciences
EXAS
$6K 0.01%
+50
New +$1.22K
1 2
3

Similar funds

KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
DP
DW Partners New York $62.3M AUM 25.52% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return

Opus Point Partners Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Opus Point Partners Management, which disclosed 57 positions worth $101M. Its ten largest holdings account for 38% of the portfolio.

Its largest position is ProShares Ultra NASDAQ Biotechnology: 76,368 shares worth $4.79M.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, followed by Miscellaneous.

  • Opus Point Partners Management's largest Q4 2014 buy was ProShares Ultra NASDAQ Biotechnology: 76,368 shares worth $4.79M.
  • Opus Point Partners Management's ten largest holdings make up 38% of its $101M portfolio in Q4 2014.
  • Opus Point Partners Management disclosed 57 positions in Q4 2014, its first 13F filing on record.

Based on Opus Point Partners Management's 13F filing for Q4 2014, filed 17 Feb 2015.